Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Archetype Analysis Identifies Distinct Profiles in Renal Transplant Recipients with Transplant Glomerulopathy Associated with Allograft Survival.

Aubert O, Higgins S, Bouatou Y, Yoo D, Raynaud M, Viglietti D, Rabant M, Hidalgo L, Glotz D, Legendre C, Delahousse M, Shah N, Sis B, Campbell P, Mengel M, Jouven X, Duong Van Huyen JP, Lefaucheur C, Loupy A.

J Am Soc Nephrol. 2019 Mar 14. pii: ASN.2018070777. doi: 10.1681/ASN.2018070777. [Epub ahead of print]

PMID:
30872323
2.

Modeling graft loss in patients with donor-specific antibody at baseline using the Birmingham-Mayo (BirMay) predictor: Implications for clinical trials.

Bentall A, Smith BH, Gonzales MM, Bonner K, Park WD, Cornell LD, Dean PG, Schinstock CA, Borrows R, Lefaucheur C, Loupy A, Stegall MD.

Am J Transplant. 2019 Feb 15. doi: 10.1111/ajt.15312. [Epub ahead of print]

PMID:
30768833
3.

Response to treatment and long-term outcomes in kidney transplant recipients with acute T cell-mediated rejection.

Bouatou Y, Viglietti D, Pievani D, Louis K, Duong Van Huyen JP, Rabant M, Aubert O, Taupin JL, Glotz D, Legendre C, Loupy A, Lefaucheur C.

Am J Transplant. 2019 Feb 12. doi: 10.1111/ajt.15299. [Epub ahead of print]

PMID:
30748089
4.

Antibody-Mediated Rejection of Solid-Organ Allografts.

Lefaucheur C, Loupy A.

N Engl J Med. 2018 Dec 27;379(26):2580-2582. doi: 10.1056/NEJMc1813976. No abstract available.

PMID:
30586534
5.

Lack of impact of pre-emptive deceased-donor kidney transplantation on graft outcomes: a propensity score-based study.

Foucher Y, Le Borgne F, Legendre C, Morelon E, Buron F, Girerd S, Ladrière M, Mourad G, Garrigue V, Glotz D, Lefaucheur C, Cassuto E, Albano L, Giral M.

Nephrol Dial Transplant. 2018 Oct 15. doi: 10.1093/ndt/gfy317. [Epub ahead of print]

PMID:
30325453
6.

Antibody-Mediated Rejection of Solid-Organ Allografts.

Loupy A, Lefaucheur C.

N Engl J Med. 2018 Sep 20;379(12):1150-1160. doi: 10.1056/NEJMra1802677. Review. No abstract available.

PMID:
30231232
7.

Value of monitoring circulating donor-reactive memory B cells to characterize antibody-mediated rejection after kidney transplantation.

Luque S, Lúcia M, Melilli E, Lefaucheur C, Crespo M, Loupy A, Bernal-Casas D, Gomà M, Jarque M, Crespo E, Montero N, Manonelles A, Cruzado JM, Gil-Vernet S, Grinyó JM, Bestard O.

Am J Transplant. 2019 Feb;19(2):368-380. doi: 10.1111/ajt.15055. Epub 2018 Sep 17.

PMID:
30085394
8.

Correction: Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis.

Bouquegneau A, Loheac C, Aubert O, Bouatou Y, Viglietti D, Empana JP, Ulloa C, Murad MH, Legendre C, Glotz D, Jackson AM, Zeevi A, Schaub S, Taupin JL, Reed EF, Friedewald JJ, Tyan DB, Süsal C, Shapiro R, Woodle ES, Hidalgo LG, O'Leary J, Montgomery RA, Kobashigawa J, Jouven X, Jabre P, Lefaucheur C, Loupy A.

PLoS Med. 2018 Jul 27;15(7):e1002637. doi: 10.1371/journal.pmed.1002637. eCollection 2018 Jul.

9.

Complement-binding anti-HLA antibodies are independent predictors of response to treatment in kidney recipients with antibody-mediated rejection.

Viglietti D, Bouatou Y, Kheav VD, Aubert O, Suberbielle-Boissel C, Glotz D, Legendre C, Taupin JL, Zeevi A, Loupy A, Lefaucheur C.

Kidney Int. 2018 Oct;94(4):773-787. doi: 10.1016/j.kint.2018.03.015. Epub 2018 May 22.

PMID:
29801667
10.

Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis.

Bouquegneau A, Loheac C, Aubert O, Bouatou Y, Viglietti D, Empana JP, Ulloa C, Murad MH, Legendre C, Glotz D, Jackson AM, Zeevi A, Schaub S, Taupin JL, Reed EF, Friedewald JJ, Tyan DB, Süsal C, Shapiro R, Woodle ES, Hidalgo LG, O'Leary J, Montgomery RA, Kobashigawa J, Jouven X, Jabre P, Lefaucheur C, Loupy A.

PLoS Med. 2018 May 25;15(5):e1002572. doi: 10.1371/journal.pmed.1002572. eCollection 2018 May. Erratum in: PLoS Med. 2018 Jul 27;15(7):e1002637.

11.

Recognition of i-IF/TA as a component of the T cell-mediated rejection spectrum: Unselected population approach vs random case selection.

Lefaucheur C, Viglietti D, Loupy A.

Am J Transplant. 2018 Mar;18(3):771-772. doi: 10.1111/ajt.14667. Epub 2018 Jan 30. No abstract available.

12.

Dynamic Prognostic Score to Predict Kidney Allograft Survival in Patients with Antibody-Mediated Rejection.

Viglietti D, Loupy A, Aubert O, Bestard O, Duong Van Huyen JP, Taupin JL, Glotz D, Legendre C, Jouven X, Delahousse M, Kamar N, Lefaucheur C.

J Am Soc Nephrol. 2018 Feb;29(2):606-619. doi: 10.1681/ASN.2017070749. Epub 2017 Dec 18.

13.

The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials.

Haas M, Loupy A, Lefaucheur C, Roufosse C, Glotz D, Seron D, Nankivell BJ, Halloran PF, Colvin RB, Akalin E, Alachkar N, Bagnasco S, Bouatou Y, Becker JU, Cornell LD, van Huyen JPD, Gibson IW, Kraus ES, Mannon RB, Naesens M, Nickeleit V, Nickerson P, Segev DL, Singh HK, Stegall M, Randhawa P, Racusen L, Solez K, Mengel M.

Am J Transplant. 2018 Feb;18(2):293-307. doi: 10.1111/ajt.14625. Epub 2018 Jan 21.

14.

T cell-mediated rejection is a major determinant of inflammation in scarred areas in kidney allografts.

Lefaucheur C, Gosset C, Rabant M, Viglietti D, Verine J, Aubert O, Louis K, Glotz D, Legendre C, Duong Van Huyen JP, Loupy A.

Am J Transplant. 2018 Feb;18(2):377-390. doi: 10.1111/ajt.14565. Epub 2017 Nov 21.

15.

Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to Treatment.

Lefaucheur C, Viglietti D, Hidalgo LG, Ratner LE, Bagnasco SM, Batal I, Aubert O, Orandi BJ, Oppenheimer F, Bestard O, Rigotti P, Reisaeter AV, Kamar N, Lebranchu Y, Duong Van Huyen JP, Bruneval P, Glotz D, Legendre C, Empana JP, Jouven X, Segev DL, Montgomery RA, Zeevi A, Halloran PF, Loupy A.

J Am Soc Nephrol. 2018 Feb;29(2):620-635. doi: 10.1681/ASN.2017050589. Epub 2017 Oct 17.

16.

Assessing rejection-related disease in kidney transplant biopsies based on archetypal analysis of molecular phenotypes.

Reeve J, Böhmig GA, Eskandary F, Einecke G, Lefaucheur C, Loupy A, Halloran PF; MMDx-Kidney study group.

JCI Insight. 2017 Jun 15;2(12). pii: 94197. doi: 10.1172/jci.insight.94197. eCollection 2017 Jun 15.

17.

Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis.

Gosset C, Viglietti D, Rabant M, Vérine J, Aubert O, Glotz D, Legendre C, Taupin JL, Duong Van-Huyen JP, Loupy A, Lefaucheur C.

Kidney Int. 2017 Sep;92(3):729-742. doi: 10.1016/j.kint.2017.03.033. Epub 2017 May 26.

PMID:
28554738
18.

Renal Arterial Mycotic Aneurysm After Kidney Transplantation.

Lazareth H, Burbach M, Gosset C, Lefaucheur C, Pashootan P, Zagdanski AM, Denis B.

Urology. 2017 Aug;106:e7-e8. doi: 10.1016/j.urology.2017.04.046. Epub 2017 May 8.

PMID:
28495504
19.

Real Time Central Assessment of Kidney Transplant Indication Biopsies by Microarrays: The INTERCOMEX Study.

Halloran PF, Reeve J, Akalin E, Aubert O, Bohmig GA, Brennan D, Bromberg J, Einecke G, Eskandary F, Gosset C, Duong Van Huyen JP, Gupta G, Lefaucheur C, Malone A, Mannon RB, Seron D, Sellares J, Weir M, Loupy A.

Am J Transplant. 2017 Nov;17(11):2851-2862. doi: 10.1111/ajt.14329. Epub 2017 May 30.

20.

Antibody-Mediated Rejection Due to Preexisting versus De Novo Donor-Specific Antibodies in Kidney Allograft Recipients.

Aubert O, Loupy A, Hidalgo L, Duong van Huyen JP, Higgins S, Viglietti D, Jouven X, Glotz D, Legendre C, Lefaucheur C, Halloran PF.

J Am Soc Nephrol. 2017 Jun;28(6):1912-1923. doi: 10.1681/ASN.2016070797. Epub 2017 Mar 2.

21.

Clinical Trials for Immunosuppression in Transplantation: The Case for Reform and Change in Direction.

OʼConnell PJ, Kuypers DR, Mannon RB, Abecassis M, Chadban SJ, Gill JS, Murphy B, Nickerson PW, Schold JD, Stock PG, Seron D, Alloway RR, Bromberg JS, Budde K, Jordan SC, Legendre C, Lefaucheur C, Sarwall M, Segev DL, Stegall MD, Tullius SG, Wong G, Woodle ES, Ascher N, Morris RE.

Transplantation. 2017 Jul;101(7):1527-1534. doi: 10.1097/TP.0000000000001648.

PMID:
28207630
22.

Gene Expression Profiling for the Identification and Classification of Antibody-Mediated Heart Rejection.

Loupy A, Duong Van Huyen JP, Hidalgo L, Reeve J, Racapé M, Aubert O, Venner JM, Falmuski K, Bories MC, Beuscart T, Guillemain R, François A, Pattier S, Toquet C, Gay A, Rouvier P, Varnous S, Leprince P, Empana JP, Lefaucheur C, Bruneval P, Jouven X, Halloran PF.

Circulation. 2017 Mar 7;135(10):917-935. doi: 10.1161/CIRCULATIONAHA.116.022907. Epub 2017 Feb 1.

PMID:
28148598
23.

From Humoral Theory to Performant Risk Stratification in Kidney Transplantation.

Lefaucheur C, Viglietti D, Mangiola M, Loupy A, Zeevi A.

J Immunol Res. 2017;2017:5201098. doi: 10.1155/2017/5201098. Epub 2017 Jan 2. Review.

24.

The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology.

Loupy A, Haas M, Solez K, Racusen L, Glotz D, Seron D, Nankivell BJ, Colvin RB, Afrouzian M, Akalin E, Alachkar N, Bagnasco S, Becker JU, Cornell L, Drachenberg C, Dragun D, de Kort H, Gibson IW, Kraus ES, Lefaucheur C, Legendre C, Liapis H, Muthukumar T, Nickeleit V, Orandi B, Park W, Rabant M, Randhawa P, Reed EF, Roufosse C, Seshan SV, Sis B, Singh HK, Schinstock C, Tambur A, Zeevi A, Mengel M.

Am J Transplant. 2017 Jan;17(1):28-41. doi: 10.1111/ajt.14107.

25.

Early Identification of Patients With Out-of-Hospital Cardiac Arrest With No Chance of Survival and Consideration for Organ Donation.

Jabre P, Bougouin W, Dumas F, Carli P, Antoine C, Jacob L, Dahan B, Beganton F, Empana JP, Marijon E, Karam N, Loupy A, Lefaucheur C, Jost D, Cariou A, Adnet F, Rea TD, Jouven X.

Ann Intern Med. 2016 Dec 6;165(11):770-778. doi: 10.7326/M16-0402. Epub 2016 Sep 13.

PMID:
27618681
26.

Value of Donor-Specific Anti-HLA Antibody Monitoring and Characterization for Risk Stratification of Kidney Allograft Loss.

Viglietti D, Loupy A, Vernerey D, Bentlejewski C, Gosset C, Aubert O, Duong van Huyen JP, Jouven X, Legendre C, Glotz D, Zeevi A, Lefaucheur C.

J Am Soc Nephrol. 2017 Feb;28(2):702-715. doi: 10.1681/ASN.2016030368. Epub 2016 Aug 4.

27.

Evidence for an important role of both complement-binding and noncomplement-binding donor-specific antibodies in renal transplantation.

Viglietti D, Lefaucheur C, Glotz D.

Curr Opin Organ Transplant. 2016 Aug;21(4):433-40. doi: 10.1097/MOT.0000000000000324. Review.

PMID:
27348472
28.

Therapeutic Hypothermia in Deceased Organ Donors and Kidney-Graft Function.

Viglietti D, Gosset C, Lefaucheur C.

N Engl J Med. 2015 Dec 31;373(27):2686-7. doi: 10.1056/NEJMc1511744. No abstract available.

PMID:
26716924
29.

C1 Inhibitor in Acute Antibody-Mediated Rejection Nonresponsive to Conventional Therapy in Kidney Transplant Recipients: A Pilot Study.

Viglietti D, Gosset C, Loupy A, Deville L, Verine J, Zeevi A, Glotz D, Lefaucheur C.

Am J Transplant. 2016 May;16(5):1596-603. doi: 10.1111/ajt.13663. Epub 2016 Mar 3.

30.

Late Failing Heart Allografts: Pathology of Cardiac Allograft Vasculopathy and Association With Antibody-Mediated Rejection.

Loupy A, Toquet C, Rouvier P, Beuscart T, Bories MC, Varnous S, Guillemain R, Pattier S, Suberbielle C, Leprince P, Lefaucheur C, Jouven X, Bruneval P, Duong Van Huyen JP.

Am J Transplant. 2016 Jan;16(1):111-20. doi: 10.1111/ajt.13529. Epub 2015 Nov 20.

31.

IgG Donor-Specific Anti-Human HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated Injury.

Lefaucheur C, Viglietti D, Bentlejewski C, Duong van Huyen JP, Vernerey D, Aubert O, Verine J, Jouven X, Legendre C, Glotz D, Loupy A, Zeevi A.

J Am Soc Nephrol. 2016 Jan;27(1):293-304. doi: 10.1681/ASN.2014111120. Epub 2015 Aug 20.

32.

Long term outcomes of transplantation using kidneys from expanded criteria donors: prospective, population based cohort study.

Aubert O, Kamar N, Vernerey D, Viglietti D, Martinez F, Duong-Van-Huyen JP, Eladari D, Empana JP, Rabant M, Verine J, Rostaing L, Congy N, Guilbeau-Frugier C, Mourad G, Garrigue V, Morelon E, Giral M, Kessler M, Ladrière M, Delahousse M, Glotz D, Legendre C, Jouven X, Lefaucheur C, Loupy A.

BMJ. 2015 Jul 31;351:h3557. doi: 10.1136/bmj.h3557.

33.

Determinants and Outcomes of Accelerated Arteriosclerosis: Major Impact of Circulating Antibodies.

Loupy A, Vernerey D, Viglietti D, Aubert O, Duong Van Huyen JP, Empana JP, Bruneval P, Glotz D, Legendre C, Jouven X, Lefaucheur C.

Circ Res. 2015 Aug 14;117(5):470-82. doi: 10.1161/CIRCRESAHA.117.306340. Epub 2015 Jun 8.

PMID:
26056252
34.

Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts.

Loupy A, Vernerey D, Tinel C, Aubert O, Duong van Huyen JP, Rabant M, Verine J, Nochy D, Empana JP, Martinez F, Glotz D, Jouven X, Legendre C, Lefaucheur C.

J Am Soc Nephrol. 2015 Jul;26(7):1721-31. doi: 10.1681/ASN.2014040399. Epub 2015 Jan 2.

35.

Complement activation in kidney transplantation: from risk stratification to therapeutic strategies.

Lefaucheur C.

Clin Exp Immunol. 2014 Dec;178 Suppl 1:57-8. doi: 10.1111/cei.12511. No abstract available.

36.

Renal allograft rejection: pieces of the puzzle.

Racusen L, Lefaucheur C.

J Am Soc Nephrol. 2015 May;26(5):1004-5. doi: 10.1681/ASN.2014090932. Epub 2014 Nov 7. No abstract available.

37.

Kidney allograft fibrosis after transplantation from uncontrolled circulatory death donors.

Viglietti D, Abboud I, Hill G, Vernerey D, Nochy D, Antoine C, Fieux F, Assayag M, Verine J, Gaudez F, Loupy A, Glotz D, Lefaucheur C.

Transplantation. 2015 Feb;99(2):409-15. doi: 10.1097/TP.0000000000000228.

PMID:
25222117
38.

New insights in antibody-mediated rejection.

Gosset C, Lefaucheur C, Glotz D.

Curr Opin Nephrol Hypertens. 2014 Nov;23(6):597-604. doi: 10.1097/MNH.0000000000000069. Review.

PMID:
25211610
39.

Molecular microscope strategy to improve risk stratification in early antibody-mediated kidney allograft rejection.

Loupy A, Lefaucheur C, Vernerey D, Chang J, Hidalgo LG, Beuscart T, Verine J, Aubert O, Dubleumortier S, Duong van Huyen JP, Jouven X, Glotz D, Legendre C, Halloran PF.

J Am Soc Nephrol. 2014 Oct;25(10):2267-77. doi: 10.1681/ASN.2013111149. Epub 2014 Apr 3.

40.

Complement-binding anti-HLA antibodies and kidney transplantation.

Lefaucheur C, Loupy A, Zeevi A.

N Engl J Med. 2014 Jan 2;370(1):85-6. doi: 10.1056/NEJMc1313506. No abstract available.

PMID:
24382075
41.

Complement-binding anti-HLA antibodies and kidney-allograft survival.

Loupy A, Lefaucheur C, Vernerey D, Prugger C, Duong van Huyen JP, Mooney N, Suberbielle C, Frémeaux-Bacchi V, Méjean A, Desgrandchamps F, Anglicheau D, Nochy D, Charron D, Empana JP, Delahousse M, Legendre C, Glotz D, Hill GS, Zeevi A, Jouven X.

N Engl J Med. 2013 Sep 26;369(13):1215-26. doi: 10.1056/NEJMoa1302506.

42.

Diagnostic criteria for kidney transplant rejection: a call to action - Authors' reply.

Loupy A, Lefaucheur C, Glotz D, Legendre C, Jouven X.

Lancet. 2013 Apr 27;381(9876):1458-9. doi: 10.1016/S0140-6736(13)60924-1. No abstract available.

PMID:
23622279
43.

Antibody-mediated vascular rejection of kidney allografts: a population-based study.

Lefaucheur C, Loupy A, Vernerey D, Duong-Van-Huyen JP, Suberbielle C, Anglicheau D, Vérine J, Beuscart T, Nochy D, Bruneval P, Charron D, Delahousse M, Empana JP, Hill GS, Glotz D, Legendre C, Jouven X.

Lancet. 2013 Jan 26;381(9863):313-9. doi: 10.1016/S0140-6736(12)61265-3. Epub 2012 Nov 23.

PMID:
23182298
44.

Preliminary results of transplantation with kidneys donated after cardiocirculatory determination of death: a French single-centre experience.

Abboud I, Viglietti D, Antoine C, Gaudez F, Meria P, Tariel E, Mongiat-Artus P, Desgranchamps F, Roussin F, Fieux F, Jacob L, Randoux C, Michel C, Flamant M, Lefaucheur C, Pillebout E, Serrato T, Peraldi MN, Glotz D.

Nephrol Dial Transplant. 2012 Jun;27(6):2583-7. doi: 10.1093/ndt/gfr709. Epub 2011 Dec 20.

PMID:
22187319
45.

Pulsatile perfusion preservation for expanded-criteria donors kidneys: Impact on delayed graft function rate.

Abboud I, Antoine C, Gaudez F, Fieux F, Lefaucheur C, Pillebout E, Viglietti D, Serrato T, Vérine J, Flamant M, Peraldi MN, Glotz D.

Int J Artif Organs. 2011 Jun;34(6):513-8. doi: 10.5301/IJAO.2011.8458.

PMID:
21725933
46.

Mastering the risk of HLA antibodies in kidney transplantation: an algorithm based on pretransplant single-antigen flow bead techniques.

Lefaucheur C, Antoine C, Suberbielle C, Glotz D.

Am J Transplant. 2011 Aug;11(8):1592-8. doi: 10.1111/j.1600-6143.2011.03560.x. Epub 2011 Jun 10.

47.

Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation.

Lefaucheur C, Loupy A, Hill GS, Andrade J, Nochy D, Antoine C, Gautreau C, Charron D, Glotz D, Suberbielle-Boissel C.

J Am Soc Nephrol. 2010 Aug;21(8):1398-406. doi: 10.1681/ASN.2009101065. Epub 2010 Jul 15.

48.

Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies.

Loupy A, Suberbielle-Boissel C, Hill GS, Lefaucheur C, Anglicheau D, Zuber J, Martinez F, Thervet E, Méjean A, Charron D, Duong van Huyen JP, Bruneval P, Legendre C, Nochy D.

Am J Transplant. 2009 Nov;9(11):2561-70. doi: 10.1111/j.1600-6143.2009.02813.x. Epub 2009 Sep 22.

49.

[Renal biopsy: methods].

Nochy D, Lefaucheur C, Bariety J.

Nephrol Ther. 2009 Jul;5(4):314-30. doi: 10.1016/j.nephro.2009.01.004. Epub 2009 May 17. Review. French.

PMID:
19447695
50.

Comparison of combination Plasmapheresis/IVIg/anti-CD20 versus high-dose IVIg in the treatment of antibody-mediated rejection.

Lefaucheur C, Nochy D, Andrade J, Verine J, Gautreau C, Charron D, Hill GS, Glotz D, Suberbielle-Boissel C.

Am J Transplant. 2009 May;9(5):1099-107. doi: 10.1111/j.1600-6143.2009.02591.x.

Supplemental Content

Loading ...
Support Center